歐洲紫杉醇於 2004 年被 FDA 批准為轉移去勢抗性攝護腺癌的治療藥物 。 然而，大多數這些患者的癌症在幾個月後對歐洲紫杉醇產生了抗藥性。 台灣綠蜂膠以其抗炎、抗氧化和抗微生物特性而著稱 ，但台灣綠蜂膠對攝護腺癌的作用和機制尚不清楚。 我們研究了台灣綠蜂膠對歐洲紫杉醇抗藥性攝護腺癌細胞 PC/DX25 細胞生長和存活的抑製效果。 我們還探討了台灣綠蜂膠對PC/DX25細胞存活和生長重要信號蛋白的影響。 我們的結果表明，台灣綠蜂膠可抑制歐洲紫杉抗藥性攝護腺癌細胞的生長與存活。;Suppressive Effects of Taiwanese Green Propolis on Docetaxel Resistant Prostate Cancer Cells
Abstract
Docetaxel is used widely for the treatment of metastasis castration resistant prostate cancer (mCRPC). However, majority of these patient’s cancer became resistant to docetaxel after months. Taiwanese green propolis (TGP) is known for its anti-inflammation, anti-oxidation, and anti-microbial properties, but the effects of TGP on prostate cancer (PCa) are unclear. We investigated the suppressive effect of TGP on proliferation and morphology of docetaxel-resistant PCa cells PC/DX25. We examined the effects of TGP on signaling proteins involved in survival and proliferation of PCa cells. Our results suggested that TGP can suppress the proliferation and survival of docetaxel-resistant PCa.
